Rayno Life Science Portfolio FMI: Personalized Medicine for Oncology
We are on vacation this week but need to update you on Roche (RHHBY) complete buyout of Foundation Medicine (FMI) one of our top picks in personalized medicine for oncology. FMI is up 28% to $136.50 in the pre-market.
We added FMI to our top picks on 7/5/16 at a price of $20.
Biotech momentum continues with green screen in a down market.The XBI our top ETF pick hit a new 52 week high yesterday at $101.18 but short of bubble levels from 2015.
Gene Therapy
Sarepta Therapeutics (SRPT) up 34% to $141 at 2p EDT on early results for gene therapy trial for Duchenne Muscular Dystrophy (DMD).
Biotech is hot! Update at close: ARRY up 8.29% to $18.95, BPMC up 2.52% to $69.53,IBB up 1.42% to $112, XBI up 1.49% to $98.90.
Even large caps pick up steam: ALXN, CELG, GILD, REGN, VRTX
